Hidradenitis suppurativa (HS) is a chronic disorder of terminal follicular epithelium in the apocrine gland‐bearing areas. The long term therapy is based mainly on topical and/or systemic antibiotic use that could result in antibiotic resistance. The aim of our study was to present the real‐life experience based on the efficacy and tolerability of a novel lotion containing triethyl‐citrate, ethyl‐linoleate, and g‐peptide‐10 in the treatment of mild to moderate HS that has already shown effectiveness in acne treatment. This was an open‐label study on 30 patients of both sexes affected by HS. Patients were divided into two groups: 15 with Hurley I and 15 with Hurley II–III. The subjects were treated with the topical lotion, three‐times‐daily for eight weeks, with control at 4 (T1) and eight weeks (T2). Any other concomitant treatment (both topical and/or systemic) was avoided during study period. Improvement was observed in both Sartorius score grading system and inflammatory and noninflammatory lesion counts. The novel lotion has proved to be effective and well‐tolerated topical agent alone or in association with other topical and/or systemic tratments in HS, without side effects

Efficacy and tolerability of a lotion containing triethyl citrate, ethyl linoleate, and GT peptide‐10 in the adjuvant treatment of hidradenitis suppurativa: Real‐life data / Skroza, N; Mambrin, A; Tolino, E; Marchesiello, A; Proietti, I; Bernardini, N; Potenza, C. - In: DERMATOLOGIC THERAPY. - ISSN 1529-8019. - 31:4(2018). [10.1111/dth.12599]

Efficacy and tolerability of a lotion containing triethyl citrate, ethyl linoleate, and GT peptide‐10 in the adjuvant treatment of hidradenitis suppurativa: Real‐life data

Skroza N
Primo
Writing – Review & Editing
;
Mambrin A
Secondo
Writing – Original Draft Preparation
;
Tolino E
Writing – Original Draft Preparation
;
Marchesiello A
Writing – Review & Editing
;
Proietti I
Writing – Review & Editing
;
Bernardini N
Penultimo
Writing – Review & Editing
;
Potenza C
Ultimo
Supervision
2018

Abstract

Hidradenitis suppurativa (HS) is a chronic disorder of terminal follicular epithelium in the apocrine gland‐bearing areas. The long term therapy is based mainly on topical and/or systemic antibiotic use that could result in antibiotic resistance. The aim of our study was to present the real‐life experience based on the efficacy and tolerability of a novel lotion containing triethyl‐citrate, ethyl‐linoleate, and g‐peptide‐10 in the treatment of mild to moderate HS that has already shown effectiveness in acne treatment. This was an open‐label study on 30 patients of both sexes affected by HS. Patients were divided into two groups: 15 with Hurley I and 15 with Hurley II–III. The subjects were treated with the topical lotion, three‐times‐daily for eight weeks, with control at 4 (T1) and eight weeks (T2). Any other concomitant treatment (both topical and/or systemic) was avoided during study period. Improvement was observed in both Sartorius score grading system and inflammatory and noninflammatory lesion counts. The novel lotion has proved to be effective and well‐tolerated topical agent alone or in association with other topical and/or systemic tratments in HS, without side effects
2018
hidradenitis suppurativa; topical therapy; triethyl citrate ethyl linoleate G -peptide 10
01 Pubblicazione su rivista::01a Articolo in rivista
Efficacy and tolerability of a lotion containing triethyl citrate, ethyl linoleate, and GT peptide‐10 in the adjuvant treatment of hidradenitis suppurativa: Real‐life data / Skroza, N; Mambrin, A; Tolino, E; Marchesiello, A; Proietti, I; Bernardini, N; Potenza, C. - In: DERMATOLOGIC THERAPY. - ISSN 1529-8019. - 31:4(2018). [10.1111/dth.12599]
File allegati a questo prodotto
File Dimensione Formato  
Skroza_Dermatologic_therapy_2018.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 607.03 kB
Formato Adobe PDF
607.03 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1183648
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact